Sarepta Therapeutics, Inc.

Company Name:
Sarepta Therapeutics, Inc. 
Transaction Type:
Follow-on Offering 
Ticker Symbol:
Deal Amount:
Transaction Date:
Transaction Summary:
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) raised $126.8 million in its follow-on offering at $39.00 per share. Needham acted as a co-manager on the transaction. The net proceeds from the sale of the shares from the offering will be used by Sarepta Therapeutics, Inc. for product and commercial development, manufacturing, any business development activities and for general corporate purposes. 
Company Description:
Sarepta Therapeutics (NASDAQ: SRPT) is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying DMD drug candidates, including its lead DMD product candidate, eteplirsen, designed to skip exon 51. Sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. 
Investment Banking